Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 9.40
-1.10 (-10.48%)
Jul 24, 2026, 5:08 PM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 97.55 million as of July 24, 2026. Its market cap has decreased by -8.29% in one year.
Market Cap
97.55M
Enterprise Value
105.16M
Revenue
4.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.40
ChartMarket Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 97.55M, an increase of 3,012.64%. That is a compound annual growth rate of 22.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 97.55M | -5.05% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 327.88M |
| PureTech Health | 299.40M |
| Faron Pharmaceuticals Oy | 90.86M |
| 4basebio | 81.58M |
| Bioventix | 79.68M |
| Ondine Biomedical | 71.44M |
| hVIVO | 51.53M |
| Hemogenyx Pharmaceuticals | 49.44M |